ProPhase Labs, Inc. (PRPH)
OTCMKTS · Delayed Price · Currency is USD
0.1602
-0.0573 (-26.34%)
At close: Jan 28, 2026
ProPhase Labs Market Cap
ProPhase Labs has a market cap or net worth of $739.79 thousand as of January 29, 2026. Its market cap has decreased by -95.23% in one year.
Market Cap
739.79K
Enterprise Value
8.02M
Revenue
5.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.16
Market Cap Chart
Since January 2, 1996, ProPhase Labs's market cap has decreased from 5.04M to 739.79K, a decrease of -85.33%. That is a compound annual growth rate of -6.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 739.79K | -64.20% |
| Dec 31, 2025 | 2.07M | -88.57% |
| Dec 31, 2024 | 18.08M | -77.84% |
| Dec 29, 2023 | 81.56M | -47.97% |
| Dec 30, 2022 | 156.75M | 41.18% |
| Dec 31, 2021 | 111.03M | 4.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioqual | 34.44M |
| Aspira Women's Health | 19.48M |
| Longduoduo Company | 17.81M |
| Psychemedics | 11.02M |
| Hypha Labs | 5.44M |
| Stella Diagnostics | 4.67M |
| Centogene | 3.58M |
| InVitro International | 3.34M |